Abstract
Background: Multiple sclerosis (MS) is an immune- mediated inflammatory disease that attacks myelinated axons in the central nervous system leading to significant disability. Worldwide, approximately 2.1 million peoples around the world are affected by MS. MS is often recognizable clinically by different patterns: Relapsing and remitting, MS (80–90%) primary progressive MS (10–20%) secondary progressive MS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have